Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HeLa cell mitotic machinery refers to the complex network of proteins and structural components, such as microtubules, centrosomes, and kinetochores, that orchestrate cell division in the HeLa cervical cancer cell line (Masters, 2002, Nature Reviews Cancer). This machinery is responsible for the accurate segregation of chromosomes during mitosis, a process that is highly accelerated and often deregulated in cancer cells (McIntosh, 2016, Cold Spring Harbor Perspectives in Biology). Key molecular components include tubulins, motor proteins like kinesins, and regulatory kinases such as Aurora kinases and Polo-like kinases (PubMed, PMC4852144). Because HeLa cells are a model for immortalized cancer growth, their mitotic machinery is a primary focus for developing antineoplastic agents. Drugs like taxanes and vinca alkaloids target this machinery by disrupting microtubule dynamics, leading to mitotic arrest and subsequent programmed cell death (Weaver, 2014, Molecular Biology of the Cell). While effective against tumors, these interventions often cause systemic toxicity due to their impact on normal dividing cells (StatPearls, NBK536911).
Disruption of microtubule polymerization or depolymerization dynamics, or inhibition of essential mitotic kinases (e.g., Aurora kinases, Polo-like kinases), to induce mitotic arrest and subsequent apoptosis (Weaver, 2014, Molecular Biology of the Cell).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HeLa cell mitotic machinery.